Fig. 1From: Combinational immune-cell therapy of natural killer cells and sorafenib for advanced hepatocellular carcinoma: a reviewThe signaling pathways of sorafenib effect on the HCC tumor progression and NK cell effector function against tumor cellsBack to article page